Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × ricolinostat × Clear all

NCT01997840 2025-03-04

ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma

Phase 1/2 Terminated

103 enrolled 21 charts

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Plasma Cell

NCT01323751 2017-04-06

ACY-1215

Phase 1/2 Completed

Multiple Myeloma